Cobots for bioproduction
Collaborative robots (cobots) that work alongside human operators without safety caging — force-torque-limited arms deployed in cell-therapy manufacturing, sterile fill-finish and lab automation, delivering measured cost and throughput gains over both manual operation and fully caged industrial robotics.
1 · What it gives
Collaborative robots, or cobots, are force-torque-limited robotic arms designed to work safely alongside human operators without the safety caging a traditional industrial robot requires, a distinction formalized under ISO/TS 15066. In bioproduction, that safety profile matters because it lets a cobot be deployed directly inside a cleanroom or biosafety cabinet workflow next to a technician, rather than isolated behind a fence in a separate zone. Documented deployments show the value proposition is not just safety but measured economics: one cell-therapy manufacturer reported a 74 percent reduction in biomanufacturing costs after deploying a robotic cluster built on collaborative arms. Applications span three distinct settings — cell and gene therapy manufacturing, where sterile, repetitive manipulation steps benefit from consistent robotic execution; sterile fill-finish and packaging, where collaborative robots handle ergonomically demanding repetitive tasks; and lab automation, where cobots increasingly pair with AI-driven orchestration software to run adaptive, closed-loop experimental workflows rather than fixed, pre-programmed sequences.
The key directions of cobots for bioproduction are:
- Force-torque-limited safety design (Collaborative Safety): cobots operate without the safety caging industrial robots require, certified under ISO/TS 15066, enabling direct deployment alongside human operators in cleanroom and lab settings.
- Cell and gene therapy manufacturing automation (Cell Therapy Automation): robotic clusters built on collaborative arms execute sterile, repetitive manufacturing steps, with documented cost reductions versus manual operation.
- AI-native lab orchestration (AI Lab Orchestration): cobots increasingly integrate with AI foundation models and adaptive orchestration platforms to run closed-loop, self-adjusting experimental workflows rather than fixed sequences.
- Sterile fill-finish and packaging robotics (Sterile Manipulation): collaborative robots handle repetitive, ergonomically demanding tasks in pharmaceutical packaging and fill-finish, deployed as sterile-compatible robot variants.
Sectoral value chain#
[Task definition] ──> [Cobot arm deployment] ──> [Force-torque-limited execution] ──> [Sterile/cleanroom task completion]
│
(safety monitoring)
│
▼
[Manufacturing/lab output] <─── [Software: orchestration, path planning, AI-driven adaptation]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Task definition | The manufacturing or lab process step is defined — a repetitive manipulation, transfer or packaging action suited to robotic execution. | In: process workflow specification. Out: defined robotic task sequence. |
| Cobot arm deployment | A force-torque-limited robotic arm is installed at the workstation, without the safety caging a traditional industrial robot requires. | In: defined task sequence, workstation layout. Out: deployed cobot ready for operation. |
| Force-torque-limited execution | The cobot executes the task while continuously monitoring force and torque to detect and stop on unexpected contact with a human or obstacle. | In: programmed task, real-time force/torque sensing. Out: completed manipulation with safety-monitored contact detection. |
| Sterile/cleanroom task completion | The cobot completes the manufacturing or lab step within cleanroom or biosafety-cabinet conditions. | In: in-process material or sample. Out: processed material/sample meeting sterility requirements. |
| Software: orchestration and adaptation | Orchestration software sequences multi-step workflows and, in AI-native deployments, adapts the workflow based on real-time data. | In: task-completion signals, sensor/assay data. Out: next-step commands, adapted workflow sequence. |
| Manufacturing/lab output | The finished manufacturing batch or experimental result is delivered downstream. | In: completed robotic workflow. Out: manufactured product or experimental dataset. |
Cross-cutting technologies of the sector:
- Force-torque sensing: continuous monitoring of contact forces lets a cobot detect unexpected collision and stop within a safety-certified response time, the core technology enabling caged-free operation.
- AI foundation-model integration: cobot platforms increasingly connect to AI models that interpret experimental data in real time, closing the loop between a lab result and the next robotic action without human intervention.
- Sterile-compatible robot variants: vendors offer robot models specifically rated for cleanroom and sterile-manufacturing environments, distinct from standard industrial-floor cobot configurations.
2 · What it replaces 3 · matched by industry
| D2E– | Drone release of beneficial insects (Trichogramma, Cotesia, predatory mites) instead of insecticide sprays Replaces: Insecticide sprays against caterpillar and mite pests, and manual walking release of natural enemies (the labour bottleneck of large-scale … | MACRO |
| D3E– | Agricultural spraying drones instead of knapsack and manned aerial spraying Replaces: Manual knapsack spraying, tractor spraying in small or wet fields, and manned aircraft/helicopter spraying | EAC |
| D3E2 | Genomic selection in dairy cattle breeding instead of progeny testing Replaces: Progeny testing — choosing AI bulls only after their daughters' milk records were available (5–6 years per bull and large testing costs) | BREED |
3 · How to implement 6 steps
- 1Task and safety zone definitionThe manufacturing or lab step is defined as a robotic task, with its safety zone and human-interaction points specified per ISO/TS 15066 collaborative-robot requirements.
- 2Cobot deploymentThe force-torque-limited robotic arm is installed at the workstation, integrated with any required sterile-compatible end effectors or cleanroom-rated materials.
- 3Sterile task executionThe cobot executes the defined manipulation, transfer or packaging task within cleanroom or biosafety-cabinet conditions, following its programmed or orchestration-driven sequence.
- 4Force-torque monitoringThroughout execution, continuous force-torque sensing monitors for unexpected contact, triggering an immediate certified stop if a collision or obstruction is detected.
- 5Orchestration handoffData, software & automationOrchestration software confirms task completion and, in AI-native deployments, incorporates real-time experimental or process data to determine the next step in the workflow.Who can do this step matched automaticallyN.Thing South Koreaindustrial scale“Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by …”163,050 tonnes“As the fundamental component of 5G deployment, optic fibre is critical to making Hong Kong a smart city and laying the groundwork for IoT.”Metso Finland“With completely new and redesigned software,”
- 6Batch or output completion
The completed manufacturing batch or experimental output is delivered downstream, with a 21 CFR Part 11-compliant audit trail documenting the robotic execution for GxP environments.
4 · Who delivers
Matched suppliers (matched automatically)
| Ginkgo Bioworks | United States | Producer | active |
| Samsung Biologics | South Korea | Producer | active |
| Thermo Fisher Scientific | United States | Producer | active |
| Cell AgriTech | Malaysia | Research / RTO | active |
| BIONET | Spain | Equipment | active |
| BioPhenolics Inc. | Japan | Producer | active |
| Caladan Bio | United States | Producer | active |
| Esco Aster | Singapore | Services / consulting | active |
| Lonza Group | Switzerland | Producer | active |
| AGC Biologics | United States | Producer | active |
| PBS Biotech | United States | Equipment | active |
In the services and supply catalogue 3 · paid service
Laboratory & analytical instruments · Spare parts, service & calibration · Process modelling & simulation
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Universal Robots | 🇩🇰 Denmark | UR cobot arms | Documented cell-therapy manufacturing and packaging-ergonomics deployments | Commercial (Teradyne subsidiary) |
| Automata | 🇬🇧 United Kingdom | LINQ platform | AI-native lab orchestration; closed-loop cell-culture workflow partnerships | Commercial |
| Yaskawa | 🇯🇵 Japan | Motoman HC series | Sterile-compatible cobots for sensitive/pharmaceutical environments | Commercial, public (TYO:6506) |
| Precise Automation (Brooks) | 🇺🇸 USA | PreciseFlex | Compact robotics for intelligent lab automation and drug discovery | Commercial (Brooks Automation) |
| Siasun Robot & Automation | 🇨🇳 China | Collaborative robot line | Leading domestic collaborative-robotics manufacturer | Commercial, public (SZSE:300024) |
5 · Rules & route to market
per shipment (veterinary and phytosanitary control)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The US hosts an established compact-robotics specialist serving lab automation and drug discovery, alongside documented cell-therapy manufacturing deployments using collaborative robotics from other regional vendors.
compact lab-automation robotics, cell-therapy manufacturing cost reduction, drug-discovery workflow deployment#
- Precise Automation (Brooks Automation): the PreciseFlex compact robot platform is positioned for intelligent lab automation, addressing lab-automation failure modes such as misaligned plates and incorrect consumable placement in drug-discovery workflows.
- Multiply Labs (deploying Universal Robots cobots): documented a 74 percent reduction in biomanufacturing costs for cell and gene therapy production using a robotic cluster built on collaborative arms, illustrating the measured economics of cobot deployment in regulated biomanufacturing.
European Union
Denmark and the UK each host a distinct cobot specialist, spanning the general-purpose collaborative-arm hardware layer and the AI-native lab-orchestration software layer.
general-purpose collaborative-arm hardware, AI-native lab orchestration, cell-culture workflow partnerships#
- Universal Robots (Denmark): UR cobots underpin the Multiply Labs cell-therapy manufacturing cluster and are documented in pharmaceutical-packaging ergonomics case studies, reflecting broad deployment across both manufacturing and packaging applications.
- Automata (United Kingdom): the LINQ lab-automation platform integrates with AI foundation models — including a partnership with CellVoyant for closed-loop, AI-powered adaptive cell-culture workflows — positioning Automata at the orchestration and AI-integration layer above the robot hardware itself.
China
Siasun is a confirmed China-headquartered cobot manufacturer, one of the EQP-kind screens this session to clear with a domestic vendor, though evidence here reflects general industry standing rather than a biopharma-specific case study.
domestic collaborative-robotics leadership, general industrial cobot manufacturing, publicly traded robotics platform#
- Siasun Robot & Automation: a leading Chinese collaborative-robotics manufacturer (Shenyang, listed SZSE:300024), confirmed through investor-relations filings, revenue disclosures and industry ranking coverage as a top domestic collaborative-robot producer; no biopharma-specific deployment case study was confirmed in this screen.
- Screening note: evidence for this entity reflects general collaborative-robotics market standing rather than a confirmed bioproduction-specific deployment, so its application to biopharma manufacturing is described qualitatively.
6 · Money: tenders & grants
| Grant | Continuing Human Enabling Enhancing Restoring and Sustaining Air Force -- Research Lab · United States | Aug 22, 2044 6482 days |
| Grant | Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not … National Institutes of Health · United States | Jan 25, 2028 428 days |
| Grant | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States | Oct 15, 2027 326 days |
| Grant | Health of ecosystems and wild species, predictions and impacts on human health, in the face of existing and … European Commission · EU | Sep 22, 2027 303 days |
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 136 days |
7 · Tech stack & innovations
The stack layers force-torque-limited hardware safety, orchestration software and increasingly AI-driven workflow adaptation on a common cobot-deployment architecture, with the choice among vendors often reflecting whether the buyer needs robot hardware, an integrated compact-robotics platform, or an AI-native orchestration layer above third-party arms.
- Force-torque collaborative safety:
- Continuous force and torque sensing along the robot’s joints detects unexpected contact and triggers a certified stop response, the core mechanism enabling operation without safety caging under ISO/TS 15066.
- Sterile-compatible variants extend this safety architecture to materials and surface finishes suitable for cleanroom and biosafety-cabinet environments.
- AI-native lab orchestration:
- Orchestration software sequences multi-step robotic workflows and, in AI-native deployments, ingests real-time experimental data to adapt the next robotic action without a human re-programming the sequence.
- Partnerships pairing an orchestration platform with an AI foundation model (interpreting cell-culture or assay data) are an emerging pattern rather than an in-house build by the robotics vendor alone.
- Compact robotics for lab automation:
- Smaller-footprint robot arms purpose-built for bench-scale lab automation address failure modes specific to that scale — misaligned microplates, faulty seals, incorrect consumable placement — that a larger industrial arm is not optimized to detect or correct.
- Positioned specifically for drug-discovery throughput pressure, where screening volume growth outpaces available human technician time.
Sources 5 · 0 independent · 5 producer sites
Producers' own sites 5
- Universal robots producer checked 2026-06-20 · link not kept
- Automata producer checked 2026-06-23 · link not kept
- Yaskawa producer checked 2026-04-05 · link not kept
- Precise automation producer checked 2026-06-08 · link not kept
- Siasun robot producer checked 2026-08-11 · link not kept